Scientists discover a way to produce true structure of naturally-occurring anti-HIV compound

Having control over how a dish is cooked is always a good idea. Taking a hint from the kitchen, scientists appear to have discovered a way to produce a true structure of the rare but naturally-occurring anti-HIV compound Lancilactone C from start to finish.

Its non-cytotoxicity in mammals could make this triterpenoid an ideal candidate for treating AIDS if its biological activity were clear -- and if only it were abundant in nature.

Now, a research group at Kyoto University has succeeded in creating a domino-like synthesis of Lancilactone C's unique seven-membered ring structure.

Our synthetic method revealed that the proposed structure of Lancilactone C was initially incorrect. But we successfully derived its true structure from our spectral data and understanding of its biosynthesis."

Chihiro Tsukano, Kyoto University's Graduate School of Agriculture

In addition to this revelation, Tsukano realized that the electrocyclization -- a rearrangement reaction in organic chemistry -- used in the total synthesis also occurs in biosynthesis. Ironically, it remains a mystery of whether the proposed structure containing an unsaturated seven-membered ring might exist in nature as an analog -- or equivalent compound -- and how it might affect the expression of biological activity.

Tsukano's team utilized the domino-like reaction to enable the total synthesis of lancilactones and related triterpenoids. This outcome has inspired the team to further their research in optimizing compound structures, leading to possible development of novel antivirals.

The endless loop of required medication and multi-drug therapies often correlates with a lower quality of life for economically burdened patients.

"Our synthetic method for Lancilactone C, with its known efficacy, may lead to developing less problematic anti-HIV drugs," concludes Tsukano.

Source:
Journal reference:

Kuroiwa, H., et al. (2023) Total Synthesis and Structure Revision of (+)-Lancilactone C. Journal of the American Chemical Society. doi.org/10.1021/jacs.3c04124.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sweden becomes first country to meet global HIV targets